Zhou J - Search Results

1

EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort.

Ge Q, Li J, Tao J, Gao R, Jin C, Zhou J, Zhang M, Hao Z, Meng J, Liang C. Ge Q, et al. Among authors: zhou j. Front Pharmacol. 2022 Sep 19;13:946637. doi: 10.3389/fphar.2022.946637. eCollection 2022. Front Pharmacol. 2022. PMID: 36199693 Free PMC article.

2

Nomogram for predicting the overall survival of patients with early-onset prostate cancer: A population-based retrospective study.

Hu Y, Qi Q, Zheng Y, Wang H, Zhou J, Hao Z, Meng J, Liang C. Hu Y, et al. Among authors: zhou j. Cancer Med. 2022 Sep;11(17):3260-3271. doi: 10.1002/cam4.4694. Epub 2022 Mar 23. Cancer Med. 2022. PMID: 35322943 Free PMC article.

3

Establishment of an age- and tumor microenvironment-related gene signature for survival prediction in prostate cancer.

Chen L, Zhang M, Zhou J, Zhang L, Liang C. Chen L, et al. Among authors: zhou j. Cancer Med. 2022 Nov;11(22):4374-4388. doi: 10.1002/cam4.4776. Epub 2022 May 9. Cancer Med. 2022. PMID: 35535438 Free PMC article.

4

Establishment of a five-enzalutamide-resistance-related-gene-based classifier for recurrence-free survival predicting of prostate cancer.

Chen J, Meng J, Liu Y, Bian Z, Niu Q, Chen J, Zhou J, Zhang L, Zhang M, Liang C. Chen J, et al. Among authors: zhou j. J Cell Mol Med. 2022 Nov;26(21):5379-5390. doi: 10.1111/jcmm.17554. Epub 2022 Sep 28. J Cell Mol Med. 2022. PMID: 36168930 Free PMC article.

5

Associated Factors for Prostate Enlargement in Chinese Adult Men Aged <40 Receiving Checkups.

Zhang X, Xiao L, Zhang L, Zhou J, Hao Z, Yang C, Liang C. Zhang X, et al. Among authors: zhou j. Int J Clin Pract. 2022 Aug 11;2022:4792451. doi: 10.1155/2022/4792451. eCollection 2022. Int J Clin Pract. 2022. PMID: 36016826 Free PMC article.

6

Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation via the NF-κB and MAPK Pathways.

Wang W, Bai J, Zhang W, Ge G, Wang Q, Liang X, Li N, Gu Y, Li M, Xu W, Yang H, Xu Y, Geng D, Zhou J. Wang W, et al. Among authors: zhou j. Front Pharmacol. 2020 May 15;11:696. doi: 10.3389/fphar.2020.00696. eCollection 2020. Front Pharmacol. 2020. PMID: 32477149 Free PMC article.

7

Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.

Qian B, Yang J, Zhou J, Hu L, Zhang S, Ren M, Qu X. Qian B, et al. Among authors: zhou j. Front Endocrinol (Lausanne). 2022 Aug 17;13:955250. doi: 10.3389/fendo.2022.955250. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060977 Free PMC article.

8

GYY4137 Promotes Mice Feeding Behavior via Arcuate Nucleus Sulfur-Sulfhydrylation and AMPK Activation.

Zhou J, Lv XH, Fan JJ, Dang LY, Dong K, Gao B, Song AQ, Wu WN. Zhou J, et al. Front Pharmacol. 2018 Aug 21;9:966. doi: 10.3389/fphar.2018.00966. eCollection 2018. Front Pharmacol. 2018. PMID: 30186182 Free PMC article.

9

Nomogram to predict risk and prognosis of synchronous lung metastasis in renal cell carcinoma: A large cohort analysis.

Lu Z, Yang C, He W, Zhou J, Xiang R. Lu Z, et al. Among authors: zhou j. Medicine (Baltimore). 2022 Jul 8;101(27):e29764. doi: 10.1097/MD.0000000000029764. Medicine (Baltimore). 2022. PMID: 35801802 Free PMC article. Clinical Trial.

10

Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study.

Lu Z, He W, Zhou J, Yang C, Xiang R. Lu Z, et al. Among authors: zhou j. J Int Med Res. 2022 Jun;50(6):3000605221105367. doi: 10.1177/03000605221105367. J Int Med Res. 2022. PMID: 35726570 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,693 results

Search Page

Filters